FR2904557B1 - Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques - Google Patents
Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiquesInfo
- Publication number
- FR2904557B1 FR2904557B1 FR0607201A FR0607201A FR2904557B1 FR 2904557 B1 FR2904557 B1 FR 2904557B1 FR 0607201 A FR0607201 A FR 0607201A FR 0607201 A FR0607201 A FR 0607201A FR 2904557 B1 FR2904557 B1 FR 2904557B1
- Authority
- FR
- France
- Prior art keywords
- preparation
- therapeutic uses
- eucalyptus extract
- novel
- novel eucalyptus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0607201A FR2904557B1 (fr) | 2006-08-01 | 2006-08-01 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
CNA2007800334763A CN101511378A (zh) | 2006-08-01 | 2007-07-27 | 桉树提取物、其制备方法和其治疗性用途 |
UAA200901761A UA99598C2 (ru) | 2006-08-01 | 2007-07-27 | Применение экстракта эвкалипта для лечения или профилактики расстройств, являющихся следствием нарушения обратного захвата дофамина и/или серотонина, и/или норадреналина |
PCT/FR2007/001309 WO2008017752A2 (fr) | 2006-08-01 | 2007-07-27 | Extrait d ' eucalyptus, son procede de preparation et ses utilisations therapeutiques |
KR1020097004185A KR20090034401A (ko) | 2006-08-01 | 2007-07-27 | 유칼립투스 추출물, 그 제조 방법 및 치료적 용도 |
US12/309,754 US20090324754A1 (en) | 2006-08-01 | 2007-07-27 | Eucalyptus extract, method of preparation and therapeutic uses thereof |
JP2009522297A JP2010500974A (ja) | 2006-08-01 | 2007-07-27 | 新規のユーカリ抽出物、その調製方法およびその治療利用法 |
BRPI0714863-1A BRPI0714863A2 (pt) | 2006-08-01 | 2007-07-27 | extrato de eucalipto, processo de preparo e utilizaÇÕes terapÊuticas do mesmo |
RU2009107166/15A RU2445112C2 (ru) | 2006-08-01 | 2007-07-27 | Новый экстракт эвкалипта, способ его получения и его терапевтическое применение |
EP07823364A EP2049133A2 (fr) | 2006-08-01 | 2007-07-27 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
AU2007283529A AU2007283529A1 (en) | 2006-08-01 | 2007-07-27 | Eucalyptus extract, method of preparation and therapeutic uses thereof |
CA002659162A CA2659162A1 (fr) | 2006-08-01 | 2007-07-27 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
NZ574429A NZ574429A (en) | 2006-08-01 | 2007-07-27 | New eucalyptus extract, method of preparation and therapeutic uses thereof |
MX2009000673A MX2009000673A (es) | 2006-08-01 | 2007-07-27 | Nuevo extracto de eucalipto, su procedimiento de preparacion y sus utilizaciones terapeuticas. |
TW096127881A TW200820961A (en) | 2006-08-01 | 2007-07-31 | Novel eucalyptus extract, process for the preparation thereof and therapeutic uses thereof |
ARP070103382A AR062165A1 (es) | 2006-08-01 | 2007-08-01 | Extracto de eucalipto, su procedimiento de preparacion y sus utilizaciones terapeuticas |
TN2009000018A TN2009000018A1 (fr) | 2006-08-01 | 2009-01-19 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
MA31575A MA30592B1 (fr) | 2006-08-01 | 2009-01-20 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
IL196788A IL196788A0 (en) | 2006-08-01 | 2009-01-29 | New eucalyptus extract, method of preparation and therapeutic uses thereof |
NO20090951A NO20090951L (no) | 2006-08-01 | 2009-03-02 | Nytt eukalyptusekstrakt, fremgangsmate for fremstilling og terapeutiske anvendelser derav |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0607201A FR2904557B1 (fr) | 2006-08-01 | 2006-08-01 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2904557A1 FR2904557A1 (fr) | 2008-02-08 |
FR2904557B1 true FR2904557B1 (fr) | 2010-04-30 |
Family
ID=37708427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0607201A Expired - Fee Related FR2904557B1 (fr) | 2006-08-01 | 2006-08-01 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
Country Status (20)
Country | Link |
---|---|
US (1) | US20090324754A1 (fr) |
EP (1) | EP2049133A2 (fr) |
JP (1) | JP2010500974A (fr) |
KR (1) | KR20090034401A (fr) |
CN (1) | CN101511378A (fr) |
AR (1) | AR062165A1 (fr) |
AU (1) | AU2007283529A1 (fr) |
BR (1) | BRPI0714863A2 (fr) |
CA (1) | CA2659162A1 (fr) |
FR (1) | FR2904557B1 (fr) |
IL (1) | IL196788A0 (fr) |
MA (1) | MA30592B1 (fr) |
MX (1) | MX2009000673A (fr) |
NO (1) | NO20090951L (fr) |
NZ (1) | NZ574429A (fr) |
RU (1) | RU2445112C2 (fr) |
TN (1) | TN2009000018A1 (fr) |
TW (1) | TW200820961A (fr) |
UA (1) | UA99598C2 (fr) |
WO (1) | WO2008017752A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2926547B1 (fr) * | 2008-01-18 | 2010-04-23 | Pf Medicament | 5-°1-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h- cyclopropa°a!naphtalen-4-yl)-3-methylbutyl!-2,4,6-trihydroxy -1,3-benzenedicarboxaldehyde en tant que medicaments. |
JP5602346B2 (ja) * | 2008-06-17 | 2014-10-08 | 株式会社ロッテ | ユーカリ抽出物の調製方法 |
GB2465228A (en) * | 2008-11-15 | 2010-05-19 | Athena Health Patents Inc | Analogues of phloroglucinols from eucalyptus plant varieties and related compounds and their use in treating neurodegenerative disorders |
CN102085169B (zh) * | 2011-01-30 | 2012-08-29 | 广州中涵生物科技有限公司 | 一种使黑头溶解同步收细毛孔的制剂 |
PT106278B (pt) * | 2012-04-26 | 2018-01-03 | Raiz Inst De Investigação Da Floresta E Papel | Método para a obtenção de um extrato rico em ácidos triterpénicos a partir da casca de eucalipto |
KR102115037B1 (ko) * | 2013-12-04 | 2020-05-25 | 코웨이 주식회사 | 상고머리 야테 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물 |
DK3082466T3 (da) * | 2013-12-18 | 2019-10-07 | Thylabisco Ab | Anvendelse af thylakoider til formindskelse af trangen til velsmagende næringsmidler |
CA3010636A1 (fr) | 2016-06-29 | 2018-01-04 | CannScience Innovations Inc. | Resines de cannabis decarboxylees, leurs utilisations et leurs procedes de fabrication |
CN109172554A (zh) * | 2018-09-06 | 2019-01-11 | 淮安安莱生物科技有限公司 | 大果桉醛c在制备治疗人肝癌的药物方面的应用 |
KR102212193B1 (ko) | 2019-07-15 | 2021-02-03 | 박경호 | 인동등 및 유칼립투스 추출물을 유효성분으로 포함하는 인지기능장애 예방 또는 치료용 조성물 |
JP7506371B2 (ja) | 2020-01-20 | 2024-06-26 | 国立大学法人浜松医科大学 | ドーパミン減少抑制剤 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2329297A1 (fr) * | 1975-10-29 | 1977-05-27 | Rougier Yves | Inhalateur buccal |
JP3365782B2 (ja) * | 1990-11-22 | 2003-01-14 | 株式会社ロッテ | 新規マクロカルパール類及びその製造法 |
DE4447336C2 (de) * | 1994-12-31 | 1996-12-19 | Goebel Hartmut J Dr Med Habil | Verwendung eines Gemisches aus Cineol und Menthol |
JPH08198765A (ja) * | 1995-01-31 | 1996-08-06 | Hayami Kinugawa | 鎮痛用医薬組成物 |
JPH11137232A (ja) * | 1997-08-02 | 1999-05-25 | Ever Bright Ind Corp | ハーブ製品 |
JP4809980B2 (ja) * | 2000-01-18 | 2011-11-09 | 長岡香料株式会社 | 抗動脈硬化症剤 |
US20010036488A1 (en) * | 2000-01-18 | 2001-11-01 | Syuichi Hayashi | Anti-obestic composition |
JP2005518381A (ja) * | 2001-12-19 | 2005-06-23 | ザ キグリー コーポレーション | 抹消神経・血管疾患の治療方法 |
JP4979181B2 (ja) * | 2003-01-31 | 2012-07-18 | 株式会社ヤクルト本社 | グリケーション阻害剤及びその利用 |
JP2005272431A (ja) * | 2004-03-24 | 2005-10-06 | Yukio Kitagawa | アロマセラピー品 |
-
2006
- 2006-08-01 FR FR0607201A patent/FR2904557B1/fr not_active Expired - Fee Related
-
2007
- 2007-07-27 UA UAA200901761A patent/UA99598C2/ru unknown
- 2007-07-27 AU AU2007283529A patent/AU2007283529A1/en not_active Abandoned
- 2007-07-27 MX MX2009000673A patent/MX2009000673A/es not_active Application Discontinuation
- 2007-07-27 NZ NZ574429A patent/NZ574429A/en not_active IP Right Cessation
- 2007-07-27 EP EP07823364A patent/EP2049133A2/fr not_active Withdrawn
- 2007-07-27 CA CA002659162A patent/CA2659162A1/fr not_active Abandoned
- 2007-07-27 JP JP2009522297A patent/JP2010500974A/ja active Pending
- 2007-07-27 BR BRPI0714863-1A patent/BRPI0714863A2/pt not_active IP Right Cessation
- 2007-07-27 CN CNA2007800334763A patent/CN101511378A/zh active Pending
- 2007-07-27 WO PCT/FR2007/001309 patent/WO2008017752A2/fr active Application Filing
- 2007-07-27 US US12/309,754 patent/US20090324754A1/en not_active Abandoned
- 2007-07-27 KR KR1020097004185A patent/KR20090034401A/ko not_active Application Discontinuation
- 2007-07-27 RU RU2009107166/15A patent/RU2445112C2/ru not_active IP Right Cessation
- 2007-07-31 TW TW096127881A patent/TW200820961A/zh unknown
- 2007-08-01 AR ARP070103382A patent/AR062165A1/es not_active Application Discontinuation
-
2009
- 2009-01-19 TN TN2009000018A patent/TN2009000018A1/fr unknown
- 2009-01-20 MA MA31575A patent/MA30592B1/fr unknown
- 2009-01-29 IL IL196788A patent/IL196788A0/en unknown
- 2009-03-02 NO NO20090951A patent/NO20090951L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ574429A (en) | 2012-01-12 |
CA2659162A1 (fr) | 2008-02-14 |
WO2008017752A2 (fr) | 2008-02-14 |
AR062165A1 (es) | 2008-10-22 |
AU2007283529A1 (en) | 2008-02-14 |
UA99598C2 (ru) | 2012-09-10 |
MX2009000673A (es) | 2009-02-04 |
TN2009000018A1 (fr) | 2010-08-19 |
FR2904557A1 (fr) | 2008-02-08 |
EP2049133A2 (fr) | 2009-04-22 |
RU2445112C2 (ru) | 2012-03-20 |
RU2009107166A (ru) | 2010-09-10 |
NO20090951L (no) | 2009-04-24 |
WO2008017752A3 (fr) | 2008-04-10 |
US20090324754A1 (en) | 2009-12-31 |
CN101511378A (zh) | 2009-08-19 |
TW200820961A (en) | 2008-05-16 |
MA30592B1 (fr) | 2009-07-01 |
BRPI0714863A2 (pt) | 2013-05-21 |
JP2010500974A (ja) | 2010-01-14 |
IL196788A0 (en) | 2009-11-18 |
KR20090034401A (ko) | 2009-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2904557B1 (fr) | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques | |
FR2898603B1 (fr) | Nouveaux polyurethanes, compositions les comprenant et procede de traitement cosmetique | |
EP1895966A4 (fr) | Procede d'extraction de ginsenoside rg2, composition pharmaceutique comprenant du ginsenoside rg2, et utilisations associees | |
IL189914A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them | |
EP1988910A4 (fr) | Conjugués de polymères contenant de l'acryloyloxyéthylphosphorylcholine et leur préparation | |
BRPI0922276A2 (pt) | "organismo microbiano de ocorrência não-natural, e , método para produzir isopropanol, 4-hidroxibutirato,e, 1,4-butanodiol." | |
ZA200609500B (en) | Adjuvanted Shiga toxin B-subunit based vaccines | |
IL195675A (en) | Human binding molecules with the ability to kill Staphylococcus preparations containing them, their method of manufacture and use | |
IL195245A0 (en) | Substituted prolinamides, production thereof and their use as drugs | |
EP2199402A4 (fr) | Cycloastragénol monoglycoside, sa préparation, composition pharmaceutique le contenant et son utilisation | |
FR2929945B1 (fr) | Procede d'extraction de mangiferine et d'isomanfigerine. | |
IL193341A0 (en) | Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments | |
FR2937972B1 (fr) | Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique | |
BRPI0914080A2 (pt) | "sistema de liberação de dosagem controlada, método de administração e processo de preparação do mesmo" | |
FR2917412B1 (fr) | Derives de 7-alkynyl, 1,8-naphthyridones, leur preparation et leur application en therapeutique | |
DE502007005902D1 (de) | -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate | |
IL184314A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
IL202820A0 (en) | Rose containing flavone and delphinidin, and method for production thereof | |
FR2891825B1 (fr) | Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique | |
FR2939136B1 (fr) | Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique | |
WO2009053628A3 (fr) | Nouveaux composes, préparation et utilisations | |
EP1919490A4 (fr) | Composition a base d'herbes medicinales pour le traitement d'infections | |
PT1603550E (pt) | Composição farmacêutica que compreende ácido 5-metil-2-2¿- (cloro-6¿-fluoroanilino)fenilacético | |
FR2889530B1 (fr) | Produit issu d'un extrait proteinique de guar, procede de preparation et utilisations | |
FR2874502B1 (fr) | Nouvel extrait vegetal, son procede d'obtention et ses applications pharmaceutiques, nutraceutiques ou cosmetiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20140430 |